Treatment of People with Evans Syndrome in the Setting of COVID-19 Pandemic
Journal of Biomedical Research & Environmental Sciences · 2020
DOI: 10.37871/jbres1137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Research & Environmental Sciences, 2020. Verfasst von AM Abbas und 2 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
A new type of pneumonia had developed from Wuhan Province in China in December 2019, caused by a novel member of the Coronaviridae family named Severe Acute Respiratory Coronavirus 2 Syndrome (SARS-CoV-2) [1]. The disease is characterized by fatigue, dry cough, fever, and dyspnea [2]. In a more severe case, the picture may become more complicated by the onset of interstitial pneumonia with alveolar damage, which clinically can lead to severe Acute Respiratory Distress Syndrome (ARDS) and even death [3]. Since the initial outbreak, the epidemic has had a rapid global spread worldwide, which led the World Health Organization (WHO) to declare the disease now called COVID-19, a pandemic on 11th March 2020 [4].
Zitieren
APA
Abbas, A., Helbawi, F., & Abdelsalam, M. (2020). Treatment of People with Evans Syndrome in the Setting of COVID-19 Pandemic. Journal of Biomedical Research & Environmental Sciences. https://doi.org/10.37871/jbres1137
Vancouver
Abbas A, Helbawi F, Abdelsalam M. Treatment of People with Evans Syndrome in the Setting of COVID-19 Pandemic. Journal of Biomedical Research & Environmental Sciences. 2020. doi:10.37871/jbres1137
BibTeX
@article{Abbas2020,
author = {Abbas, AM and Helbawi, FM and Abdelsalam, MH},
title = {Treatment of People with Evans Syndrome in the Setting of COVID-19 Pandemic},
journal = {Journal of Biomedical Research & Environmental Sciences},
year = {2020},
doi = {10.37871/jbres1137}
}
EUVIMED